AcuityMD Press releases

AcuityMD Brings Prescription Data Into AcuityAI, Helping MedTech Reps Find New Patients Through Healthcare Professionals (HCPs)

September 29, 2026

AI-powered insights help commercial teams identify top-prescribing HCPs whose patients may be candidates for their devices

AcuityMD Ranked No. 316 on the 2026 Inc. 5000 List, The Most Prestigious Ranking of America’s Fastest-Growing Private Companies

August 12, 2026

MedTech AI leader recognized for 1,061% three-year revenue growth – topping the software category at no. 28 – and now valued at $955 million

AcuityMD Now Trusted By More Than 500 Medical Device Companies, Including 16 of Top 20

July 22, 2026

Rapid growth reflects seismic shift toward greater use of AI across the MedTech industry

New Research Finds Medical Device Sales Reps Using AI are 3x More Likely to Meet or Exceed Quota

July 14, 2026

Survey also finds most reps use AI for administrative tasks versus strategic account intelligence

AcuityMD Launches the AcuityMD Encounters Data Mart on Snowflake Marketplace

June 18, 2026

Joint customers can access MedTech procedure and provider data directly within Snowflake with the AcuityMD Encounters Data Mart.

AcuityMD Lands $80 Million in New Funding to Fuel AI Innovation in Medical Device (MedTech) Industry

April 21, 2026

 Nearing $1B valuation and poised for rapid growth, AcuityMD introduces AcuityAI

New Report Shows Increase in Colorectal Screenings at Ambulatory Surgery Centers (ASCs) Versus Hospitals

March 10, 2026

Volume of endoscopic and laparoscopic colorectal procedures performed in an outpatient setting increased 50% – improving patient access and creating opportunities for device companies.

AcuityMD Announces AcuityMD for Salesforce on Salesforce AppExchange

February 18, 2026

AcuityMD’s customers can now benefit from a Salesforce integration that unifies market intelligence and rep-centric workflows.

Electromedical Products International (EPI) expands access of unique medical technology to veterans experiencing anxiety, insomnia, pain

November 11, 2025

In recognition of Veterans Day, AcuityMD announces its partnership with Electromedical Products International (EPI) to drive access to Alpha-Stim®, a non-invasive, FDA-cleared device.

Preceptis Medical selects AcuityMD for expansion of breakthrough in-office pediatric ear tube device

October 21, 2025

AcuityMD’s data and insights drive commercial growth of important new option to families seeking alternatives for routine ear tube placement in millions of children.

AcuityMD makes the Forbes’ 2025 “Next Billion-Dollar Startups” list

August 13, 2025

AcuityMD has been named to Forbes’ 2025 “Next Billion-Dollar Startups” list – an elite group of 25 venture-backed U.S. companies identified as most likely to reach a $1 billion valuation. The list has a strong track record: more than 100 startups named in the past 10 years have since become unicorns.

AcuityMD expands Care Journeys solution with enhanced physician referral networks to increase patient access to MedTech innovations

April 28, 2025

Early adopter Teleflex benefits from comprehensive view of patient referral pathways to fast-track greater adoption of its breakthrough innovation in men’s health.

AcuityMD signs 300th MedTech customer, Teleflex

March 11, 2025

MedTech intelligence platform provider exceeds expectations in 2024 with two product launches, doubling its workforce, and large funding raise.

AcuityMD Presents New Outpatient Spinal Surgery Data at American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting

March 6, 2025

Share of spinal surgeries performed in an outpatient setting increasing 8% year over year – improving patient experience, reducing financial burden, creating opportunities for device companies.

Profound Medical standardizes on AcuityMD intelligence platform for MedTech as foundation for growing organization

February 26, 2025

AcuityMD platform helps drive the first incision-free, radiation-free robotic treatment for prostate disease faster to more healthcare providers nationwide.

AcuityMD launches ‘Care Journeys’ to help MedTech companies speed delivery of breakthrough innovation to the right patients

October 15, 2024

Care Journeys empowers commercial teams to demonstrate the value of their products to physicians, hospitals, and independent delivery networks (IDNs), driving revenue and improving patient care.

New contracts solution for medical device industry accelerates sales cycles, increases revenues, and maximizes contract performance

September 24, 2024

AcuityMD’s novel solution helps reduce missed opportunities due to poorly managed contracts; and speeds close rates – for one medical device company – by 66%.

Survey reveals 100% of MedTech executives say poor contract management causes revenue to be left on the table

September 23, 2024

80% of respondents believe that contracts are a “significant” revenue driver, and two-thirds report that at least 70% of company revenue now comes through contracts.

Pristine Surgical selects AcuityMD MedTech commercial intelligence platform to launch first-in-class product and expand into new markets

August 28, 2024

AcuityMD today announced that its commercial intelligence platform for medical technology (MedTech) companies has been selected by Pristine Surgical, a medical device company with a mission to simplify endoscopy.

6 of the top 10 medical device manufacturers rely on AcuityMD's commercial intelligence platform to modernize operations, drive revenue

June 4, 2024

AcuityMD now supports more than 200 MedTech companies, including leaders BD and SI-Bone.

AcuityMD secures $45m in Series B funding to expand its commercial intelligence platform to medical technology manufacturers

June 4, 2024

AcuityMD today announced $45 million in new funding to expand its commercial intelligence platform and advance the company’s mission of accelerating adoption of cutting-edge medical technology (MedTech).

LivsMed selects AcuityMD to accelerate adoption of ArtiSential Instruments for optimal results at less cost than robotics

October 21, 2023

AcuityMD’s platform helps emerging MedTech company solve commercialization challenges.

Intellijoint selects AcuityMD platform to accelerate commercialization of surgical navigation solution

October 10, 2023

Intellijoint Surgical selected AcuityMD to support the commercial launch of its hip and knee navigation solutions and grow its U.S. presence.

AcuityMD launches ‘Pipeline’ to enable MedTech commercial teams to forecast with accuracy and improve sales planning

September 26, 2023

AcuityMD, provider of a novel commercial platform for medical technology (MedTech) companies, announced the launch of Pipeline, a new module that enables sales representatives to execute on prospects throughout the sales lifecycle, track progress, forecast accurately, and ultimately improve business planning to grow revenue.

Olympus adopts AcuityMD across the enterprise to power an expanding omnichannel engagement strategy

September 12, 2023

AcuityMD has expanded its partnership with Olympus Corporation, a top 20 MedTech company that delivers advanced diagnostic, therapeutic, and minimally invasive procedures to healthcare professionals.

AcuityMD signs Miach Orthopedics, now over 100 medical device customers

August 15, 2023

AcuityMD’s data-driven commercial platform has helped device innovators identify more than 60,000 untapped healthcare professionals and over $6 billion in opportunity value.

FEMSelect breaks into U.S. Market with AcuityMD to speed market access for its minimally invasive women’s health device

May 3, 2023

FEMSelect, an Israeli-based MedTech startup, partners with AcuityMD to accelerate identification and engagement of U.S. physicians treating pelvic floor disorders (PFD).

AcuityMD increases annual revenue by 300+%; customer and staff growth by 250%

December 6, 2022

New data-driven, commercial platform for medical technology companies fills market need in a fast-growing industry, forecasted CAGR of 5.5% through 2029.

Spark Biomedical & AcuityMD partner to treat opioid use

October 20, 2022

AcuityMD accelerates widespread market access to novel opioid withdrawal treatment device, currently in use across 24 U.S. rehabilitation facilities.

AcuityMD raises $31M in Series A funding

May 12, 2022

Today we’re excited to share that AcuityMD has raised $31M in Series A funding led by Redpoint Venture Partners, with support from Benchmark, the leader of our seed round, as well as Ajax Health and Artisanal Ventures.

Dilon Technologies selects AcuityMD platform to accelerate its preventative breast cancer surgery devices to more oncologists

April 4, 2022

AcuityMD enables Dilon to quickly identify the right doctors and medical facilities in urgent need of its life-saving medical technology.